Exophiala dermatitidis: Infections, Symptoms & Treatment

Exophiala dermatitidis is a darkly pigmented “black yeast” fungus that, despite being uncommon, can cause a striking range of infections in humans, from superficial skin lesions to fatal brain abscesses. Unlike most fungi in its group, E. dermatitidis has an unusual preference for internal organs over skin, with the lungs, central nervous system, and bloodstream being its most frequent targets. The fungus thrives in warm, moist, acidic environments, and its ability to survive conditions that kill most other microbes makes it a persistent and underappreciated hazard for people with weakened immune systems or certain genetic vulnerabilities.

What Exophiala dermatitidis Actually Is

E. dermatitidis belongs to a group of fungi collectively called “black yeasts” because of their dark melanin pigments. Under the microscope, the organism is dimorphic, meaning it can switch between yeast and filamentous (mold-like) forms. Budding yeast cells dominate during active growth, but older, thick-walled cells can convert into hyphal structures. This shape-shifting ability is part of what makes the fungus adaptable. Its small conidia, roughly 2.5–4 micrometers in length, appear in clusters and can become airborne. On culture plates, colonies grow slowly and look smooth, waxy, and almost black, sometimes leaching dark pigment into the surrounding medium. No sexual reproductive form has ever been discovered, so E. dermatitidis is classified as strictly asexual.¹

That melanin is not just cosmetic. Laboratory work has shown that melanin protects E. dermatitidis from being killed inside the immune system’s frontline defense cells, specifically neutrophils. The pigment does not stop the immune cells from swallowing the fungus, nor does it prevent them from launching their usual chemical attack. Instead, it shields the fungus from the destructive molecules generated during that attack, allowing it to survive inside the very cells meant to destroy it.² This built-in armor is a big part of why the organism can establish deep-seated infections even in people whose immune systems are functioning reasonably well.

Where the Fungus Lives

The natural habitat of E. dermatitidis appears to be tropical and subtropical environments. Researchers have isolated it from the droppings of fruit-eating birds and bats, from tropical fruits, and from warm, humid natural settings. The hypothesis is that the fungus evolved in association with frugivorous animals in tropical rainforests, with living cells passing through the animals’ digestive tracts and being deposited in feces. Its ability to tolerate heat, low pH, and low nutrient levels all point toward adaptations to this kind of life cycle.³

In the built environment, the fungus has found an unexpected niche: dishwashers. A study examining household dishwashers found E. dermatitidis present in nearly half of them, mostly colonizing the rubber door seals at concentrations up to a million colony-forming units per square centimeter. The fungus also turned up on side nozzles, doors, and drains. More troubling, hot aerosols produced during dishwasher cycles were shown to carry the organism into the surrounding kitchen, meaning the machine can actively disperse the fungus into a home’s air. Kitchens with dishwashers had a higher prevalence of black yeasts compared to kitchens without them.⁴ The combination of warmth, moisture, detergent residues, and alkaline-to-acidic pH swings inside a dishwasher creates a selective environment where E. dermatitidis outcompetes many other microbes.

Steam baths, saunas, and railway ties treated with creosote have also yielded the fungus. The common thread is any warm, wet setting where most competitors are eliminated but E. dermatitidis, with its thermotolerance and chemical resilience, can persist.

Who Is at Risk

Most healthy people who encounter E. dermatitidis will never develop an infection. The fungus is an opportunist, and it typically needs an opening. The largest at-risk groups include people on immunosuppressive drugs (organ transplant recipients, patients receiving chemotherapy or biologics), people living with HIV/AIDS, and patients with chronic lung diseases, especially cystic fibrosis.

A particularly interesting genetic risk factor involves a protein called CARD9, which plays a role in the immune system’s recognition of fungal invaders. Researchers have documented cases of otherwise healthy young adults developing severe, invasive E. dermatitidis infections that were ultimately traced to inherited CARD9 deficiency. The recommendation from case analyses is that CARD9 deficiency should be considered in any patient who develops unexplained invasive Exophiala disease, even if no other infections are present.⁵ This matters because the patient can look entirely healthy aside from the fungal infection, which can lead clinicians to overlook the underlying immune defect.

Types of Infection and Their Symptoms

E. dermatitidis stands apart from many other black yeasts in a counterintuitive way: despite its species name (“dermatitidis,” implying skin), it is actually less likely to infect the skin and subcutaneous tissue than other Exophiala species. A systematic review found that E. dermatitidis carries significantly higher odds of infecting the lungs, central nervous system, and blood compared to other species in the same genus, and significantly lower odds of causing skin or subcutaneous infections.⁶ The name, it turns out, is misleading.

Lung Infections

Pulmonary involvement is the most common presentation, and people with cystic fibrosis are the group most frequently affected. The fungus colonizes the thick, sticky mucus in CF airways, and it can be difficult to detect because it grows slowly on standard culture media. In one study, all E. dermatitidis isolations from sputum occurred only after more than 48 hours of incubation, meaning routine cultures that are read at the standard timeframe can miss it entirely.⁷

Whether colonization with E. dermatitidis actually harms CF patients is an area of genuine disagreement in the medical literature. A retrospective study of adult CF patients found that the rate of lung function decline roughly doubled after E. dermatitidis was first isolated, from about −0.34% per year before detection to −1.82% per year afterward, a statistically significant difference.⁸ On the other hand, a study focused on children with CF found no clinically significant difference in lung function, antibiotic use, or body mass between those who harbored Exophiala and matched controls.⁹ A separate study looking at acute pulmonary exacerbations in CF similarly found no difference in treatment response or outcomes over 12 months between patients who grew E. dermatitidis and those who did not.⁷

The picture that emerges is complicated. In adults with CF, chronic colonization may contribute to a faster decline in lung function over years, but finding the fungus during an acute flare-up does not seem to make that episode worse. In children, the impact appears to be milder or absent. Clinicians dealing with CF patients who test positive for E. dermatitidis have to weigh whether to treat aggressively or to monitor, and the evidence does not yet provide a clean answer.

Central Nervous System Infections

Brain infections caused by E. dermatitidis are rare but devastating. The fungus has a documented affinity for neural tissue, and genomic studies have identified gene domains in certain brain-derived strains that are shared with another notoriously brain-invading black fungus, Rhinocladiella mackenziei.¹⁰ This neurotropism is not fully understood, but the clinical consequences are serious.

Case reports describe patients presenting with progressive intracranial pressure, persistent coma, and multiple brain and spinal cord lesions visible on imaging. In one case, a previously healthy young man who had been diagnosed with neck lymph node infection from E. dermatitidis and treated with itraconazole went on to develop cerebral disease seven months later, eventually dying from brain herniation despite treatment.¹¹ In another, a previously healthy 3-year-old child developed intracranial hypertension, paraplegia, urinary retention, and constipation from multiple brain and spinal lesions.¹² Both cases occurred in people with no obvious immune deficiency at the time of presentation, though the adult was later found to carry a CARD9 mutation. These cases underscore that CNS involvement can occur even when the patient does not appear immunocompromised by conventional standards.

Bloodstream and Disseminated Infections

When E. dermatitidis enters the bloodstream, it can seed multiple organs simultaneously. Disseminated disease has been reported in patients on immunosuppressive therapy, including a case where the fungus caused both bone infection (osteomyelitis) and joint infection (septic arthritis), requiring aggressive surgery alongside prolonged antifungal treatment to achieve a positive outcome.¹³ Bloodstream infections have also been documented in neonates with central venous catheters, a setting where the catheter itself can serve as a portal of entry for the fungus.

How the Infection Is Diagnosed

Identifying E. dermatitidis in the lab is trickier than it sounds. The slow growth rate means cultures can be discarded as negative before colonies appear. The dark, yeast-like colonies can resemble other fungi, and traditional identification methods based on visual characteristics of the organism under the microscope can be unreliable for black yeasts as a group.

A technology called MALDI-TOF mass spectrometry has improved identification considerably. The technique works by generating a protein fingerprint from whole cells and matching it against a reference library. Studies have shown that with an adequate reference database, MALDI-TOF correctly identified E. dermatitidis clinical isolates to the species level in nearly all cases tested, with results matching those obtained by DNA sequencing.¹⁴¹⁵ The caveat is that commercial MALDI-TOF databases do not always include black yeasts, so labs may need to build custom spectral libraries to get reliable results. DNA sequencing of specific gene regions remains the gold standard when MALDI-TOF is inconclusive or unavailable.

For clinicians, the practical takeaway is that a culture growing slowly in the lab that produces a dark, yeast-like colony should raise suspicion. If the patient has cystic fibrosis, a weakened immune system, or an unexplained deep infection, requesting extended incubation and molecular or mass spectrometry-based identification can mean the difference between catching and missing this diagnosis.

Treatment Options

E. dermatitidis infections generally require prolonged antifungal therapy, and in many cases surgery as well. The choice of antifungal drug matters because the organism’s susceptibility profile is lopsided. In vitro testing of 81 strains found that posaconazole and itraconazole had the strongest activity, with voriconazole and amphotericin B also showing adequate potency. The echinocandin class of antifungals, which includes caspofungin and anidulafungin, performed poorly, requiring much higher concentrations to inhibit growth. Fluconazole, one of the most commonly prescribed antifungals, also showed relatively weak activity.¹⁶

For deep-seated or disseminated infections, treatment recommendations favor aggressive approaches. A combination of surgical removal of infected tissue and prolonged antifungal therapy is often necessary.¹⁷ In neonatal bloodstream infections, where the source is often a central venous catheter, removing the catheter is a key step. Recommendations from case analyses suggest at least three weeks of treatment with an azole (itraconazole or fluconazole guided by susceptibility testing) or amphotericin B alone, and advise against echinocandins or the combination of amphotericin B plus an azole, which can be antagonistic for this organism.¹⁸

CNS infections present the hardest treatment challenge. The fungus must be reached behind the blood-brain barrier, limiting drug options. Voriconazole penetrates brain tissue better than most other azoles and is often the drug of choice for cerebral disease, sometimes in combination with amphotericin B. Even so, the mortality rate for CNS phaeohyphomycosis remains high, particularly when diagnosis is delayed.

The Dishwasher Problem and Practical Prevention

The finding that dishwashers serve as reservoirs for E. dermatitidis is one of those results that sounds alarming at first glance. Nearly half of tested machines harbored the fungus, and it was being aerosolized into kitchens. But context matters: for most people with intact immune systems, exposure to these low-level environmental concentrations is not going to cause disease. The concern is specifically for immunocompromised household members or people with chronic lung conditions like cystic fibrosis, who may inhale aerosolized cells during or after a wash cycle.

Practical steps to reduce fungal buildup in dishwashers include periodically cleaning the rubber door seals and drain area with diluted bleach or a commercial appliance cleaner, running a hot empty cycle with a descaling agent, and leaving the door ajar after a cycle to allow the interior to dry. The fungus thrives where moisture lingers, so anything that reduces persistent dampness helps. Whether these measures are worth the effort depends on your household. If everyone in the home is healthy, the risk is minimal. If someone in the home is on immunosuppressive therapy or has CF, paying attention to dishwasher hygiene is a reasonable precaution.

Genomic Clues to the Fungus’s Behavior

Whole-genome comparisons between E. dermatitidis and a close relative, Exophiala spinifera, have turned up a paradox. E. dermatitidis, the more frequently encountered human pathogen of the two, actually has a smaller genome and fewer genes associated with virulence than E. spinifera and even some purely environmental (non-pathogenic) relatives.¹⁰ In other words, this fungus does not appear to have evolved a particularly elaborate toolkit for attacking humans. Its success as a pathogen may owe more to its stress-tolerance traits (melanin, heat resistance, acid tolerance, ability to form capsules) that originally evolved for environmental survival rather than to any sophisticated human-targeting machinery.

One finding that stands out is the identification of a specific gene domain found exclusively in E. dermatitidis strains isolated from human brain tissue, a domain shared with the famously neurotropic fungus R. mackenziei. Whether this gene contributes to the ability to invade neural tissue or is simply a marker of strains that happen to reach the brain remains an open question, but it reinforces the idea that brain-invading black yeasts may share underlying biological features that researchers have only begun to catalog.

When Melanin Is a Weapon

The role of melanin in E. dermatitidis pathogenesis goes beyond a passive shield. Laboratory experiments comparing wild-type (melanized) strains with melanin-deficient mutants found that melanin specifically prevents the fungus from being killed inside neutrophil phagolysosomes, the compartments where immune cells digest foreign invaders. Phagocytosis itself was unaffected: immune cells engulfed melanized and non-melanized fungal cells at similar rates. The oxidative burst, the chemical barrage launched against ingested pathogens, also fired normally. But the melanized cells survived it, while the non-melanized mutants did not.² Interestingly, carotenoid pigments (torulene and torularhodine) produced by the same fungus did not contribute to survival, suggesting that melanin is the specific molecule responsible.

This has practical implications for treatment. Reducing melanin production could theoretically make the fungus more vulnerable to the immune system, opening the door to adjunctive therapies. Lab work has shown that growing E. dermatitidis in acidic, ascorbate-containing media reduces melanization and makes the cells more susceptible to enzymatic digestion.¹⁹ No melanin-targeting drug is available for clinical use yet, but the concept of stripping the fungus of its armor rather than trying to poison it directly is an area that researchers continue to explore.